Johnson & Johnson vs Zoetis Inc.
JNJ vs ZTS — side-by-side comparison from reported financials. JNJ leads 4, ZTS leads 6 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Zoetis Inc.
ZTS · Healthcare
$73.90+1.12%Mixed
| Metric | JNJ | ZTS |
|---|---|---|
| Price | $261.79 | $73.90 |
| Market cap | $631B | $30.5B |
| Revenue (TTM) | $97.9B | $9.52B |
| Revenue growth | +5.6% | +5.4% |
| Net margin | 21.5% | 27.5% |
| Free cash flow | $22.2B | $2.37B |
| Net cash (debt) | ($27.8B) | ($6.73B) |
| 1-year price return | +37.0% | -48.5% |
| P/E | 29.9 | 11.8 |
| P/E vs own history (cheap-side %) | 16% | 97% |
| Dividend yield | 2.00% | 2.89% |
| Return on equity | 26% | 69% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 14,500 |
Full résumé-style profiles: JNJ CV · ZTS CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.